Log in to save to my catalogue

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2542363250

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Minimally invasive approaches to detect residual disease after surgery are needed to identify patients with cancer who are at risk for metastatic relapse. Circulating tumour DNA (ctDNA) holds promise as a biomarker for molecular residual disease and relapse
1
. We evaluated outcomes in 581 patients who had undergone surgery and were evaluable...

Alternative Titles

Full title

ctDNA guiding adjuvant immunotherapy in urothelial carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2542363250

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2542363250

Other Identifiers

ISSN

0028-0836

E-ISSN

1476-4687

DOI

10.1038/s41586-021-03642-9

How to access this item